Cardiac amyloidosis with asymmetrical septal hypertrophy and deterioration after nifedipine.

Suppr

超能文献

作者信息

Griffiths B E, Hughes P, Dowdle R, Stephens M R

出版信息

Thorax. 1982 Sep;37(9):711-2. doi: 10.1136/thx.37.9.711.

DOI:10.1136/thx.37.9.711

PMID:6891504

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC459412/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/48d1/459412/86e62f8f4a58/thorax00201-0073-a.jpg

相似文献

Cardiac amyloidosis with asymmetrical septal hypertrophy and deterioration after nifedipine.

Thorax. 1982 Sep;37(9):711-2. doi: 10.1136/thx.37.9.711.

Adverse effects of nifedipine therapy on hypertrophic obstructive cardiomyopathy.

Chest. 1983 Apr;83(4):704-6. doi: 10.1378/chest.83.4.704.

[Acute action of nifedipine in patients with obstructive and nonobstructive asymmetrical septum hypertrophy (ASH)].

Med Welt. 1980 Sep 26;31(39):1408-11.

Effects of nifedipine and propranolol combined therapy in patients with hypertrophic cardiomyopathy.

Z Kardiol. 1987;76 Suppl 3:105-12.

[Acute effects of nifedipine in hypertrophic cardiomyopathy. Echocardiographic and hemodynamic study].

Boll Soc Ital Cardiol. 1981;26(12):1973-7.

Nifedipine in hypertrophic cardiomyopathy.

Circulation. 1982 Aug;66(2):478-9.

Improved diastolic function and systolic performance in hypertrophic cardiomyopathy after nifedipine.

N Engl J Med. 1980 Oct 2;303(14):801-3. doi: 10.1056/NEJM198010023031407.

[Nifedipine in hypertrophic obstructive cardiomyopathy].

Dtsch Med Wochenschr. 1982 Dec 3;107(48):1842-6. doi: 10.1055/s-2008-1070218.

[Nifedipine in the treatment of hypertrophic non-obstructive cardiomyopathy].

Schweiz Med Wochenschr. 1982 Sep 18;112(38):1312-7.

[Risks of beta-blockers and calcium inhibitors in amyloid cardiopathy].

Presse Med. 1986 May 24;15(21):981.

引用本文的文献

Emerging from the Darkness. Sudden Cardiac Death in Cardiac Amyloidosis.走出黑暗。心脏淀粉样变性中的心脏性猝死。

Rev Cardiovasc Med. 2022 Oct 14;23(10):345. doi: 10.31083/j.rcm2310345. eCollection 2022 Oct.

Arrhythmic Manifestations of Cardiac Amyloidosis: Challenges in Risk Stratification and Clinical Management.心脏淀粉样变性的心律失常表现：风险分层与临床管理中的挑战

J Clin Med. 2023 Mar 29;12(7):2581. doi: 10.3390/jcm12072581.

Two Decades of Cardiac Amyloidosis: A Danish Nationwide Study.二十年的心脏淀粉样变性：一项丹麦全国性研究。

JACC CardioOncol. 2021 Aug 17;3(4):522-533. doi: 10.1016/j.jaccao.2021.05.004. eCollection 2021 Oct.

Electrophysiological Manifestations of Cardiac Amyloidosis: State-of-the-Art Review.心脏淀粉样变的电生理表现：最新综述

JACC CardioOncol. 2021 Oct 19;3(4):506-515. doi: 10.1016/j.jaccao.2021.07.010. eCollection 2021 Oct.

Clinical management of amyloid cardiomyopathy.淀粉样心肌病的临床管理。

Heart Fail Rev. 2022 Sep;27(5):1549-1557. doi: 10.1007/s10741-021-10159-w. Epub 2021 Sep 1.

Diagnosis and treatment of cardiac amyloidosis: position statement of the German Cardiac Society (DGK).心脏淀粉样变性的诊断和治疗：德国心脏病学会（DGK）立场声明。

Clin Res Cardiol. 2021 Apr;110(4):479-506. doi: 10.1007/s00392-020-01799-3. Epub 2021 Jan 18.

Amyloid and the Heart.淀粉样变与心脏

Curr Cardiol Rep. 2019 Dec 3;21(12):164. doi: 10.1007/s11886-019-1230-9.

Features of atrial fibrillation in wild-type transthyretin cardiac amyloidosis: a systematic review and clinical experience.野生型转甲状腺素蛋白心脏淀粉样变中房颤的特征：系统评价和临床经验。

ESC Heart Fail. 2018 Oct;5(5):772-779. doi: 10.1002/ehf2.12308. Epub 2018 Jun 19.

Wild-type transthyretin cardiac amyloidosis (ATTRwt-CA), previously known as senile cardiac amyloidosis: clinical presentation, diagnosis, management and emerging therapies.野生型转甲状腺素蛋白心脏淀粉样变性（ATTRwt-CA），以前称为老年心脏淀粉样变性：临床表现、诊断、管理及新兴疗法。

J Thorac Dis. 2018 Mar;10(3):2034-2045. doi: 10.21037/jtd.2018.03.134.

Transthyretin Cardiac Amyloidosis.转甲状腺素蛋白心脏淀粉样变性

Curr Cardiol Rep. 2017 Aug 24;19(10):97. doi: 10.1007/s11886-017-0911-5.

本文引用的文献

M-mode and two-dimensional echocardiographic features in cardiac amyloidosis.心脏淀粉样变性的M型和二维超声心动图特征

Circulation. 1981 Jan;63(1):188-96. doi: 10.1161/01.cir.63.1.188.

Pulmonary oedema precipitated by nifedipine.

Br Med J. 1980 Jun 14;280(6229):1420-1. doi: 10.1136/bmj.280.6229.1420.

Improved diastolic function and systolic performance in hypertrophic cardiomyopathy after nifedipine.

N Engl J Med. 1980 Oct 2;303(14):801-3. doi: 10.1056/NEJM198010023031407.

M mode echocardiography in hypertrophic cardiomyopathy: diagnostic criteria and prediction of obstruction.

Am J Cardiol. 1980 Jan;45(1):6-14. doi: 10.1016/0002-9149(80)90213-1.

Nifedipine and beta-blocker drugs.硝苯地平和β受体阻滞剂药物。

Br Med J. 1980 Nov 8;281(6250):1251-2. doi: 10.1136/bmj.281.6250.1251-a.

Idiopathic hypertrophic subaortic stenosis afflicted: idols of the cave and the marketplace.

Am J Cardiol. 1977 Sep;40(3):476-9. doi: 10.1016/0002-9149(77)90176-x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验